These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27533083)

  • 1. Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.
    Dai CH; Chen P; Li J; Lan T; Chen YC; Qian H; Chen K; Li MY
    Oncotarget; 2016 Oct; 7(40):65157-65170. PubMed ID: 27533083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair.
    Li XQ; Ren J; Chen P; Chen YJ; Wu M; Wu Y; Chen K; Li J
    Acta Pharmacol Sin; 2018 Aug; 39(8):1359-1372. PubMed ID: 29849128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
    Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
    J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
    Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T
    Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of RAD52 and POLQ in chromosomal break repair and replication stress response.
    Kelso AA; Lopezcolorado FW; Bhargava R; Stark JM
    PLoS Genet; 2019 Aug; 15(8):e1008319. PubMed ID: 31381562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P; Li J; Jiang HG; Lan T; Chen YC
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ.
    Song L; McNeil EM; Ritchie AM; Astell KR; Gourley C; Melton DW
    BMC Cancer; 2017 Dec; 17(1):864. PubMed ID: 29254481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
    Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
    Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PolH Transcript with a Short 3'UTR Enhances PolH Expression and Mediates Cisplatin Resistance.
    Zhang J; Sun W; Ren C; Kong X; Yan W; Chen X
    Cancer Res; 2019 Jul; 79(14):3714-3724. PubMed ID: 31064846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy.
    Schrempf A; Slyskova J; Loizou JI
    Trends Cancer; 2021 Feb; 7(2):98-111. PubMed ID: 33109489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
    Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POLQ plays a key role in the repair of CRISPR/Cas9-induced double-stranded breaks in the moss Physcomitrella patens.
    Mara K; Charlot F; Guyon-Debast A; Schaefer DG; Collonnier C; Grelon M; Nogué F
    New Phytol; 2019 May; 222(3):1380-1391. PubMed ID: 30636294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin.
    Inoue A; Kikuchi S; Hishiki A; Shao Y; Heath R; Evison BJ; Actis M; Canman CE; Hashimoto H; Fujii N
    J Biol Chem; 2014 Mar; 289(10):7109-7120. PubMed ID: 24474685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase θ inhibition steps on the cGAS pedal.
    Smith CM; Gupta GP
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.
    Vassel FM; Bian K; Walker GC; Hemann MT
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28922-28924. PubMed ID: 33144509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of DNA repair pathways in cisplatin resistant lung cancer.
    O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
    Albertella MR; Green CM; Lehmann AR; O'Connor MJ
    Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
    Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
    Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broad requirement for TLS polymerases η and κ, and interacting sumoylation and nuclear pore proteins, in lesion bypass during C. elegans embryogenesis.
    Roerink SF; Koole W; Stapel LC; Romeijn RJ; Tijsterman M
    PLoS Genet; 2012 Jun; 8(6):e1002800. PubMed ID: 22761594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.